These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25769845)

  • 1. Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.
    Langsenlehner T; Pichler M; Thurner EM; Krenn-Pilko S; Stojakovic T; Gerger A; Langsenlehner U
    Urol Oncol; 2015 May; 33(5):201.e9-16. PubMed ID: 25769845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy.
    Wang Y; Xu F; Pan J; Zhu Y; Shao X; Sha J; Wang Z; Cai Y; Liu Q; Dong B; Xue W; Huang Y
    BMC Cancer; 2016 May; 16():329. PubMed ID: 27222030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
    Langsenlehner T; Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Gerger A; Pichler M
    World J Urol; 2015 Nov; 33(11):1661-7. PubMed ID: 25617235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
    Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
    Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
    Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
    Kim SH; Lee HW; Go SI; Lee SI; Lee GW
    Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
    Qi Q; Geng Y; Sun M; Wang P; Chen Z
    Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
    Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
    Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Tumour Biol; 2016 Jan; 37(1):361-8. PubMed ID: 26219894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
    Jiang R; Zou X; Hu W; Fan YY; Yan Y; Zhang MX; You R; Sun R; Luo DH; Chen QY; Huang PY; Hua YJ; Guo L; Chen MY
    Tumour Biol; 2015 Sep; 36(10):7775-87. PubMed ID: 25944165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.
    Zhang WW; Liu KJ; Hu GL; Liang WJ
    Tumour Biol; 2015 Nov; 36(11):8831-7. PubMed ID: 26063409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Thurner EM; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Br J Cancer; 2014 May; 110(10):2524-30. PubMed ID: 24675383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.
    Messager M; Neofytou K; Chaudry MA; Allum WH
    Eur J Surg Oncol; 2015 Oct; 41(10):1316-23. PubMed ID: 26166786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.
    Fu Y; Chen X; Song Y; Huang X; Chen Q; Lv X; Gao P; Wang Z
    BMC Cancer; 2021 Jul; 21(1):792. PubMed ID: 34238262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    World J Urol; 2015 Oct; 33(10):1467-73. PubMed ID: 25475065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet to lymphocyte ratio in peripheral blood and body mass index: novel independent prognostic factors in patients with melanoma].
    Qi YL; Zhang Y; Zhao LD; Wang AX; Wang ZB; Gao QL
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3704-3710. PubMed ID: 29325323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.